Skip to Content
Merck
CN
  • O-GlcNAc modification of small heat shock proteins enhances their anti-amyloid chaperone activity.

O-GlcNAc modification of small heat shock proteins enhances their anti-amyloid chaperone activity.

Nature chemistry (2021-03-17)
Aaron T Balana, Paul M Levine, Timothy W Craven, Somnath Mukherjee, Nichole J Pedowitz, Stuart P Moon, Terry T Takahashi, Christian F W Becker, David Baker, Matthew R Pratt
ABSTRACT

A major role for the intracellular post-translational modification O-GlcNAc appears to be the inhibition of protein aggregation. Most of the previous studies in this area focused on O-GlcNAc modification of the amyloid-forming proteins themselves. Here we used synthetic protein chemistry to discover that O-GlcNAc also activates the anti-amyloid activity of certain small heat shock proteins (sHSPs), a potentially more important modification event that can act broadly and substoichiometrically. More specifically, we found that O-GlcNAc increases the ability of sHSPs to block the amyloid formation of both α-synuclein and Aβ(1-42). Mechanistically, we show that O-GlcNAc near the sHSP IXI-domain prevents its ability to intramolecularly compete with substrate binding. Finally, we found that, although O-GlcNAc levels are globally reduced in Alzheimer's disease brains, the modification of relevant sHSPs is either maintained or increased, which suggests a mechanism to maintain these potentially protective O-GlcNAc modifications. Our results have important implications for neurodegenerative diseases associated with amyloid formation and potentially other areas of sHSP biology.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Amyloid beta fibrils, clone M98, Rabbit Monoclonal Antibody, clone M98, from rabbit
Sigma-Aldrich
Proteinase K from Tritirachium album, lyophilized powder, BioUltra, ≥30 units/mg protein, for molecular biology